The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...
Zacks.com on MSN3d
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...
Dexcom previews new data for 15-day glucose monitor Dexcom shared the first data for its 15 ... The trial also found that ...
First for Women on MSN9d
MDs Share 5 Things To Know About Blood Sugar Monitors—Even if You Don't Have DiabetesThe latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...
CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.
will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous ...
AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback